Clinical trials
Helminthiasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 3 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| University of Washington | 3 |
| DBL -Institute for Health Research and Development | 2 |
| Drugs for Neglected Diseases | 2 |
| Jennifer Keiser | 2 |
| London School of Hygiene and Tropical Medicine | 2 |
| Universidad Nacional de Salta | 2 |
| Albert Schweitzer Hospital | 1 |
| Alejandro Krolewiecki | 1 |
| Barcelona Institute for Global Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Helminthiasis | 36 |
| Anemia | 5 |
| Filariasis | 4 |
| Hookworm Infections | 4 |
| Parasitic Diseases | 4 |
| Coinfection | 3 |
| HIV Infections | 3 |
| Nematode Infections | 3 |
| Onchocerciasis | 3 |
| Schistosomiasis | 3 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.